Evidence map›Paper›PMID 39574125›Full record

ArticleJournal of nanobiotechnology2024

Three-arm polyrotaxanes with multidirectional molecular motions as the nanocarrier for nitric oxide-enhanced photodynamic therapy against bacterial biofilms in septic arthritis.

Shixin Liu, Yuanfang Jiang, Yu Zhang, Kai Lv, Jiaxin Zhu, Mei Liu, Hao Xu, Genlong Jiao, Wanyong Yang, Guodong Sun and 1 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shixin LiuGuangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan, 517000, China.
Yuanfang JiangDepartment of Nuclear Medicine, PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Yu ZhangDepartment of Ultrasound Medicine, Zhucheng People's Hospital, Zhucheng, 262200, China.
Kai LvKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.
Jiaxin ZhuKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.
Mei LiuKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China.
Hao XuDepartment of Nuclear Medicine, PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Genlong JiaoDongguan Key Laboratory of Central Nervous System Injury and Repair / Department of Orthopedic Surgery, The Sixth Affiliated Hospital of Jinan University (Dongguan), Dongguan, 523573, China.
Wanyong YangThe Fifth Affiliated Hospital, Jinan University, Heyuan, 517000, China. kfyang_1973@163.com.
Guodong SunGuangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan, 517000, China. sgd96@jnu.edu.cn.
Dong MaGuangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan, 517000, China. tmadong@jnu.edu.cn.

Funding

China Postdoctoral Science Foundation 2024M751133Key Projects of Dongguan Science and Technology Bureau 20221800905542Medical Joint Fund of Jinan University YXJC2022011National Natural Science Foundation of China 32171369National Natural Science Foundation of China 82171372Natural Science Foundation of Guangdong Province 2022A1515140171Natural Science Foundation of Guangdong Province 2314050001613Science and Technology Projects in Guangzhou 2023A03J0618Science and Technology Projects in Guangzhou 33121179
6 · The paper itself

Abstract

Bacterial biofilms are one of the major contributors to the refractoriness of septic arthritis. Although nitric oxide (NO)-enhanced photodynamic (PDT) therapy has been involved in biofilm eradication, the anti-biofilm efficacy is usually hindered by the short half-life and limited diffusion distance of active molecules. Herein, we report a three-arm structure using the photosensitive core chlorin e6 to integrate three α-cyclodextrin (α-CD) polyrotaxane chains as the supramolecular nanocarrier of NO-enhanced PDT therapy, in which NO was loaded on the cationic rings (α-CDs). Beneficial from the enhanced permeability of the nanocarrier due to the collective act on biofilms by the molecular motions (slide and rotation of rings) of three chains in different directions, NO capable of inducing biofilm dispersal and reactive oxygen species were efficiently delivered deep inside biofilms under 660 nm laser irradiation, and reactive nitrogen species with stronger bactericidal ability was produced in-situ, further accomplishing bacteria elimination inside biofilms. In-vivo therapeutic performance of this platform was demonstrated in a rat septic arthritis model by eliminating the methicillin-resistant Staphylococcus aureus infection, and potentiating the immune microenvironment regulation and bone loss inhibition, also providing a promising strategy to numerous obstinate clinical infections caused by biofilms.

Indexed as

Arthritis, InfectiousBiofilmsMethicillin-Resistant Staphylococcus aureusNitric OxidePhotochemotherapyRotaxanesAnimalsAnti-Bacterial AgentsChlorophyllidesDrug CarriersMaleNanoparticlesPhotosensitizing AgentsPorphyrinsRatsRats, Sprague-DawleyAnti-Bacterial AgentsChlorophyllidesDrug CarriersNitric OxidePhotosensitizing AgentsphytochlorinPorphyrinsReactive Oxygen SpeciesRotaxanesAnti-biofilm therapyMultidirectional molecular motionsNO-enhanced PDTPolyrotaxanesSeptic arthritis

Identifiers

PMID39574125
PMCPMC11583641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.